At Supernus, we hold a fundamental belief that our science has the potential to improve the lives of people with Parkinson’s disease (PD). Our commitment to people with Parkinson’s and their care partners is reflected in all that we do. Our pipeline of development projects, along with our three currently available PD treatments, reflects our resolve to bring innovative solutions to the Parkinson’s community.
To learn more about our available PD therapies visit: https://www.supernus.com/commercial-products
Products and/or Services Available
- APOKYN (apomorphine hydrochloride injection)
- XADAGO (safinamide) tablets